Related Experiment Video

Updated: Mar 8, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

9.0K

Animal models suggest the TRIP8b-HCN interaction is a therapeutic target for major depressive disorder

Kyle A Lyman1, Ye Han1, Dane M Chetkovich1

  • 1a Davee Department of Neurology and Clinical Neurosciences , Northwestern University , Chicago , IL , USA.

Expert Opinion on Therapeutic Targets
|January 28, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
HCNPex5TRIP8bdepressionion channel

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.2K
Developing a Rat Model for Bipolar Disorder04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.6K

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K